Publication Cover
Journal of Dual Diagnosis
research and practice in substance abuse comorbidity
Volume 10, 2014 - Issue 2
237
Views
13
CrossRef citations to date
0
Altmetric
SERVICES & POLICY

Dual Diagnosis Resource Needs in Spain: A National Survey of Professionals

, MD, , MD, , MD, , MD, , MD PhD, , MD, , MA, , MD PhD, , MD PhD & , MD PhD show all
Pages 84-90 | Received 03 Sep 2013, Accepted 25 Feb 2014, Published online: 05 May 2014

REFERENCES

  • Adamson, S.J., Todd, F.C., Sellman, J.D., Huriwai, T., & Porter J. (2006). Co-existing psychiatric disorders in a New Zealand outpatients alcohol and other drug clinical population. Australian and New Zealand Journal of Psychiatry, 40(2), 164–170. doi:10.1080/j.1440-1614.2006.01764.x
  • Arias, F., Szerman, N., Vega, P., Mesias, B., Basurte, I., Morant, C., … Babin, F. (2013a). Abuse or dependence on cannabis and other psychiatric disorders. Madrid study on dual pathology prevalence. Actas Espanolas de Psiquiatria, 41(2), 122–129. doi:10.1016/j.rpsm.2012.09.002
  • Arias, F., Szerman, N., Vega, P., Mesias, B., Basurte, I., Morant, C., … Babin, F. (2013b). Alcohol abuse or dependence and other psychiatric disorders. Madrid study on the prevalence of dual pathology, Mental Health and Substance Use. Actas Espanolas de Psiquiatria, 41(2), 123–130. doi:10.1080/17523281.2012.748674
  • Arias, F., Szerman, N., Vega, P., Mesias, B., Basurte, I., Morant, C., … Babín, F. (2013c). [Madrid study on the prevalence and characteristics of outpatients with dual pathology in community mental health and substance misuse services]. Adicciones, 25(1), 118–127.
  • Baldacchino, A. (2007). Co-morbid substance misuse and mental health problems: Policy and practice in Scotland. American Journal on Addictions, 16(3), 147–159.
  • Banerjee, S., Clancy, C., & Crome, I. (2002). Co-existing problems of mental disorder and substance misuse (dual diagnosis): An information manual. London: Royal College of Psychiatrists Research Unit.
  • Brunette, M.F., & Mueser, K.T. (2006). Psychosocial interventions for the long-term management of patients with severe mental illness and co-occurring substance use disorder. Journal of Clinical Psychiatry, 67(7), 10–17.
  • Casas, M., Arranz, F.J. , & Roncero, C. (2009). Grupo de estudio sobre intervenciones clínicas en conductas adictivas: GICCA: Documento de conclusiones. Barcelona: Drug Farma.
  • Compton, W.M., Conway, K.P., Stinson, F.S., Colliver, J.D., & Grant, B.F. (2005). Prevalence, correlates, and comorbidity of DSM-IV antisocial personality syndromes and alcohol and specific drug use disorders in the United States: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Journal of Clinical Psychiatry, 66(6), 677–685.
  • Daigre, C., Roncero, C., Grau-López, L., Martínez-Luna, N., Prat, G., Valero, S., … Casas, M. (2013). Attention deficit hyperactivity disorder in cocaine-dependent adults: A psychiatric comorbidity analysis. American Journal on Addictions, 22(5), 466–473. doi:10.1111/j.1521-0391.2013.12047.x
  • De las Cuevas, C. (2003). [Burnout in addiction treatment professionals]. Transtornos Adictivos, 5(2), 107–113.
  • Farren, C.K., Hill, K.P., & Weiss, R.D. (2012). Bipolar disorder and alcohol use disorder: A review. Current Psychiatry Reports, 14(6), 659–666. doi:10.1007/s11920-012-0320-9
  • Gadermann, A.M., Alonso, J., Vilagut, G., Zaslavsky, A.M., & Kessler, R.C. (2012). Comorbidity and disease burden in the National Comorbidity Survey Replication (NCS-R). Depression and Anxiety, 29(9), 797–806. doi:10.1002/da.21924
  • Grant, B.F., Stinson, F.S., Dawson, D.A., Chou, S.P., Dufour, M.C., Compton, W., … Kaplan, K. (2004). Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Archives of General Psychiatry, 61(8), 807–816. doi:10.1001/archpsyc.61.8.807
  • Grau-López, L., Roncero, C., Daigre, C., Miquel, L., Barral, C., Collazos, F., & Casas, M. (2014). Observation study of pharmacotherapy in a dual diagnosis program. Journal of Addition Medicine, 8(1), 74–75. doi:10.1097/ADM.0000000000000028
  • Green, A.I. (2006). Treatment of schizophrenia and comorbid substance abuse: Pharmacologic approaches. Journal of Clinical Psychiatry, 67, 31–35.
  • Green, A.I., & Brown, E.S. (2006). Comorbid schizophrenia and substance abuse. Journal of Clinical Psychiatry, 67(9), e08.
  • Hasin, D., Fenton, M.C., Skodol, A., Krueger, R., Keyes, K., Geier, T., … Grant, B. (2011). Personality disorders and the 3-year course of alcohol, drug, and nicotine use disorders. Archives of General Psychiatry, 68(11), 1158–1167. doi:10.1001/archgenpsychiatry.2011.78
  • Hawkins, E.H. (2009). A tale of two systems: Co-occurring mental health and substance abuse disorders treatment for adolescents. Annual Review of Psychology, 60, 197–227. doi:10.1146/annurev.psych.60.110707.163456
  • Hintz, T., & Mann, K. (2006). Co-occurring disorders: Policy and practice in Germany. American Journal on Addictions, 15(4), 261–267.
  • Kessler, R.C. (2004). The epidemiology of dual diagnosis. Biological Psychiatry, 56(10), 730–737. doi:10.1016/j.biopsych.2004.06.034
  • Kessler, R.C., Chiu, W.T., Demler, O., Merikangas, K.R., & Walters, E.E. (2005). Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry, 62(6), 617–627. doi:10.1001/archpsyc.62.6.617
  • Kessler, R.C., McGonagle, K.A., Zhao, S., Nelson, C.B., Hughes, M., Eshleman, S., … Kendler, K.S. (1994). Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Archives of General Psychiatry, 51(1), 8–19.
  • Kessler, R.C., Nelson, C.B., McGonagle, K.A., Edlund, M.J., Frank, R.G., & Leaf, P.J. (1996). The epidemiology of co-occurring addictive and mental disorders: Implications for prevention and service utilization. American Journal of Orthopsychiatry, 66(1), 17–31.
  • Lev-Ran, S., Imtiaz, S., Rehm, J., & Le Foll, B. (2013). Exploring the association between lifetime prevalence of mental illness and transition from substance use to substance use disorders: Results from the National Epidemiologic Survey of Alcohol and Related Conditions (NESARC). American Journal on Addictions, 22(2), 93–98. doi:10.1111/j.1521-0391.2013.00304.x
  • Lingford-Hughes, A.R., Welch, S., Peters, L., Nutt, D.J., & British Association for Psychopharmacology, Expert Reviewers Group. (2012). BAP updated guidelines: Evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: Recommendations from BAP. Journal of Psychopharmacology, 26(7), 899–952. doi:10.1177/0269881112444324
  • Martinez-Raga, J., Knecht, C., de Alvaro, R., Szerman, N., & Ruiz, P. (2013). Addressing dual diagnosis patients suffering from attention-deficit hyperactivity disorders and comorbid substance use disorders: A review of treatment considerations. Addictive Disorders & Their Treatment, 12(4), 213–230.
  • Olivares, J.M., Alptekin, K., Azorin, J.M., Cañas, F., Dubois, V., Emsley, R., … Schreiner, A. (2013). Psychiatrists’ awareness of adherence to antipsychotic medication in patients with schizophrenia: Results from a survey conducted across Europe, the Middle East, and Africa. Patient Preference and Adherence, 7, 121–132. doi:10.2147/PPA.S37534
  • Oller-Canet, S., Fernández-San Martín, M.I., García-Lecina, R., Castro Rodríguez, J.I., Font-Canal, T., & Lacasta-Tintorer, D. (2011). Do depressed patients comply with treatments prescribed? A cross-sectional study of adherence to the antidepressant treatment. Actas Espanolas de Psiquiatria, 39(5), 288–293.
  • Pedrero, E.J., Puerta, C., Lagares, A., Sáez, A., & García, I. (2004). [Study of burnout in professionals of drug dependencies]. Trastornos Adictivos, 6(1), 5–15.
  • Pettinati, H.M., O’Brien, C.P., & Dundon, W.D. (2013). Current status of co-occurring mood and substance use disorders: A new therapeutic target. The American Journal of Psychiatry, 170(1), 23–30. doi:10.1176/appi.ajp.2012.12010112
  • Pulay, A.J., Stinson, F.S., Ruan, W.J., Smith, S.M., Pickering, R.P., Dawson, D.A., & Grant, B.F. (2010). The relationship of DSM-IV personality disorders to nicotine dependence-results from a national survey. Drug and Alcohol Dependence, 108(1–2), 141–145. doi:10.1016/j.drugalcdep.2009.12.004
  • Regier, D.A., Farmer, M.E., Rae, D.S., Locke, B.Z., Keith, S.J., Judd, L.L., & Goodwin, F.K. (1990). Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) study. JAMA: The Journal of the American Medical Association, 264(19), 2511–2518. doi:10.1001/jama.1990.03450190043026
  • Roncero, C., Barral, C., Grau-Lopez, L., Bachiller, D., Szerman, N., Casas, M., & Ruiz, P. (2011). Protocols of dual diagnosis intervention in schizophrenia. Addictive Disorders and Their Treatment, 10(3), 131–154. doi:10.1097/ADT.0b013e318227ecdc
  • Roncero, C., Fuste, G., Barral, C., Rodríguez-Cintas, L., Martínez-Luna, N., Eiroa-Orosa, F.J., & Casas, M. (2011). Therapeutic management and comorbidities in opiate-dependent patients undergoing a replacement therapy programme in Spain: The PROTEUS study. Heroin Addiction and Related Clinical Problems, 13(3), 5–16.
  • Roncero, C., Gómez-Baeza, S., Vázquez, J.M., Terán, A., Szerman, N., Casas, M., & Bobes, J. (2013). Perception of Spanish professionals on Therapeutic Adherence of Dual Diagnosis Patients. Actas Españolas de Psiquiatría, 41(6), 319–329.
  • Rush, B., & Koegl, C.J. (2008). Prevalence and profile of people with co-occurring mental and substance use disorders within a comprehensive mental health system. Canadian Journal of Psychiatry, 53(12), 810–821.
  • Swendsen, J., Conway, K.P., Degenhardt, L., Glantz, M., Jin, R., Merikangas, K.R., … Kessler, R.C. (2010). Mental disorders as risk factors for substance use, abuse and dependence: Results from the 10-year follow-up of the National Comorbidity Survey. Addiction, 105(6), 1117–1128. doi:10.1111/j.1360-0443.2010.02902.x
  • Szerman, N., Lopez-Castroman, J., Arias, F., Morant, C., Babín, F., Mesías, B., … Baca-García, E. (2012). Dual diagnosis and suicide risk in a Spanish outpatient sample. Substance Use & Misuse, 47(4), 383–389. doi:10.3109/10826084.2011.636135
  • Szerman, N., Martínez-Raga, J., Peris, L., Roncero, C., Basurte, I., Vega, P., … Casas, M. (2013). Rethinking dual disorders/pathology. Addictive Disorders and Their Treatment, 12(1), 1–10. doi:10.1097/ADT.0b013e31826e7b6a
  • Thylstrup, B., & Johansen, K.S. (2009). Dual diagnosis and psychosocial interventions–Introduction and commentary. Nordic Journal of Psychiatry, 63(3), 202–208. doi:10.1080/08039480802571069
  • Torrens, M. (2008). [Dual diagnosis: actual situation and future prospects]. Adicciones, 20(4), 315–320.
  • Velligan, D.I., Leiden, P.J., Sajatovic, M., Scott, J., Carpenter, D., Ross, R., & Docherty, J.P. (2010). Assessment of adherence problems in patients with serious and persistent mental illness: Recommendations from the Expert Consensus Guidelines. Journal of Psychiatric Practice, 16(1), 34–45.
  • Volkow, N.D. (2007). Addiction and co-ocurring mental disorders. Director's perspective. NIDA Notes, 21, 2.
  • Volkow, N. (2001). Drug abuse and mental illness: Progress in understanding comorbidity. The American Journal of Psychiatry, 158, 1181–1183.
  • Weaver, T., Madden, P., Charles, V., Stimson, G., Renton, A., Tyrer, P., … Comorbidity of Substance Misuse and Mental Illness Collaborative (COSMIC) study team. (2003). Comorbidity of substance misuse and mental illness in community mental health and substance misuse services. The British Journal of Psychiatry, 183, 304–313. doi:10.1192/02-623
  • World Health Organization. (1994). Lexicon of alcohol and drug terms. Geneva, Switzerland: Author.
  • Zaleski, M., Laranjeira, R.R., Marques, A.C., Ratto, L., Romano, M., Alves, H.N., … Brazilian Association of Studies on Alcohol and Other Drugs. (2006). [Guidelines of the Brazilian Association of Studies on Alcohol and Other Drugs (ABEAD) for diagnoses and treatment of psychiatric comorbidity with alcohol and other drugs dependence]. Revista Brasileira de Psiquiatria, 28(2), 142–148. doi:10.1590/S1516-44462006000-200013

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.